Skip to Main Content

Paper Details

What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task Force.
J Prev Alzheimers Dis
6
2018
Author NameAffiliation
Paul S AisenUniversity of Southern California Alzheimer's Therapeutic Research Institute
  • 1 - 1

Datasets

Release 1.2